Estradiol Patch
Product Images NDC 50090-7985

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Estradiol (NDC 50090-7985). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Estradiol Structural Formula (Image 01)

Estradiol Structural Formula (Image 01)
FDA Label Image

Transdermal Parts (Image 02)

Transdermal Parts (Image 02)
This is a description of a layered product with the following components: foam backing with an adhesive layer, polyester film, acrylate adhesive matrix, and a protective liner containing Estradiol.*
FDA Label Image

Figure 1 Mean Serum 17β-estradiol Concentrations Vs. Time Profile Following Application Of A 7.75 Cm2 Transdermal Patch And Application Of A 15.5 Cm2 Estradiol Transdermal System Continuous Delivery (once-weekly) Patch (Image 03)

Figure 1 Mean Serum 17β-estradiol Concentrations Vs. Time Profile Following Application Of A 7.75 Cm2 Transdermal Patch And Application Of A 15.5 Cm2 Estradiol Transdermal System Continuous Delivery (once-weekly) Patch (Image 03)
This text appears to be a table or chart showing data related to the Estradiol Transdermal System. It includes values such as time in hours and possibly measurements in centimeters. It seems to be a comparison or representation of different aspects related to the Estradiol Transdermal System.*
FDA Label Image

Figure 2 Observed Mean (± S.e.) Estradiol Serum Concentrations For A One Week Application Of The Estradiol Transdermal System Continuous Delivery (once-weekly) (31 Cm2) To The Abdomen And Buttocks Of 38 Postmenopausal Women (Image 04)

Figure 2 Observed Mean (± S.e.) Estradiol Serum Concentrations For A One Week Application Of The Estradiol Transdermal System Continuous Delivery (once-weekly) (31 Cm2) To The Abdomen And Buttocks Of 38 Postmenopausal Women (Image 04)
FDA Label Image

Figure 3 Mean Percent Change From Baseline In Lumbar Spine (a-p View) Bone Mineral Density By Treatment And Time Last Observation Carried Forward (Image 05)

Figure 3 Mean Percent Change From Baseline In Lumbar Spine (a-p View) Bone Mineral Density By Treatment And Time Last Observation Carried Forward (Image 05)
FDA Label Image

Figure 4 Mean Percent Change From Baseline In Total Hip By Treatment And Time Last Observation Carried Forward (Image 06)

Figure 4 Mean Percent Change From Baseline In Total Hip By Treatment And Time Last Observation Carried Forward (Image 06)
FDA Label Image

Instructions For Use Figure A (Image 07)

Instructions For Use Figure A (Image 07)
FDA Label Image

Instructions For Use Figures B And C (Image 08)

Instructions For Use Figures B And C (Image 08)
This text describes instructions related to an estradiol patch with additional tear notches. It provides guidance on carefully removing the patch. Figure B and Figure C may be illustrations or diagrams accompanying the text.*
FDA Label Image

Instructions For Use Figures D And E (Image 09)

Instructions For Use Figures D And E (Image 09)
This text contains information about an Estradiol patch, including protective inner layers. The patch is used for hormone therapy.*
FDA Label Image

Instructions For Use Figures F And G (Image 10)

Instructions For Use Figures F And G (Image 10)
FDA Label Image

Instructions For Use Figure H (Image 11)

Instructions For Use Figure H (Image 11)
FDA Label Image

Label Image (Lbl500907985)

Label Image (Lbl500907985)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.